4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-21-066133
Chief Executive Officer acquired 224,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hansen Carl L. G. Chief Executive Officer | 2021-11-18 | Option exercise | +224,500 | $15.03 | $3,374,235 | 224,500 | D |
| Derivatives | |||||||
| Hansen Carl L. G. Chief Executive Officer | 2021-11-18 | Option exercise · Share option (right to buy) | −224,500 | 4,992,810 | D | ||
Loading xslF345X03/doc4.xml…